AkditalCAS:AKT +0.76%84 Days Payable is 95.44 as of Dec. 2025, which is 65% below its 10-year median of 274.55. GuruFocus rates CAS:AKT with a GF Score™ of 84/100 and a GF Value™ of MAD2,102.26 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Akdital ranks better than 68.04% on this metric.
Akdital's average Accounts Payable for the
six
months ended in Dec. 2025 was MAD618 Mil. Akdital's Cost of Goods Sold for the
six
months ended in Dec. 2025 was MAD1,182 Mil.
Hence, Akdital's Days Payable for the
six
months ended in Dec. 2025 was 95.44.
The historical rank and industry rank for Akdital's Days Payable or its related term are showing as below:
CAS:AKT'
s Days Payable Range Over the Past 10 Years
Min: 93 Med: 274.55 Max: 676.94
Current: 95.02
During the past 7 years, Akdital's highest Days Payable was 676.94. The lowest was 93.00. And the median was 274.55.
CAS:AKT's Days Payable is ranked better than 68.04% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58.16
vs CAS:AKT: 95.02
Akdital's Days Payable
declined
from Dec. 2024 (125.05) to Dec. 2025 (95.44).
It may suggest that Akditalaccelerated paying its suppliers.
Akdital Days Payable Related Terms
Akdital Days Payable Historical Data
* Premium members only.
The historical data trend for Akdital's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Akdital's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akdital Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Akdital's Days Payable distribution charts can be found below:
* The bar in red indicates where Akdital's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Akdital's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akdital (CAS:AKT) has a Days Payable of 95.44 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Akdital and its competitors. This is 65% below median its historical median of 274.55. Over the past decade, Akdital's Days Payable has ranged from 93.00 to 676.94. According to the industry distribution chart, Akdital ranks #194 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 32%.
Is Akdital's Days Payable too high?
Akdital's current Days Payable of 95.44 is 65% below median its 10-year median of 274.55. Over the past 10 years, this metric has ranged from a low of 93.00 to a high of 676.94. The Healthcare Providers & Services industry median Days Payable is 58.16. Akdital's value of 95.44 is 64.1% above this industry median. Based on the distribution chart, Akdital ranks #194 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Akdital has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Akdital's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Akdital ranks #194 out of 607 companies for Days Payable. This puts Akdital in the upper half of its industry. The industry median Days Payable is 58.16. Akdital's value of 95.44 is 64.1% above this benchmark. Historically, Akdital's own Days Payable has ranged from 93.00 to 676.94 over the past decade. While the company's 10-year median is 274.55 vs. the industry median of 58.16, Akdital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.16, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Akdital's current Days Payable of 95.44 is 64.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Akdital and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akdital's current Days Payable is 95.44, which is 65% below median its own 10-year median of 274.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akdital stock overvalued right now?
Based on GuruFocus' analysis, Akdital (CAS:AKT) is currently considered Possible Value Trap. The stock's GF Value™ is MAD2,102.26, compared to a current price of MAD1,189.00 — trading 43.4% below its estimated fair value. The current Days Payable is 95.44, which is 65% below median its 10-year median of 274.55 and 64.1% above the Healthcare Providers & Services industry median of 58.16. Akdital's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Akdital (CAS:AKT), the current Days Payable is 95.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Akdital (CAS:AKT) Overvalued in 2026?
Based on GuruFocus' analysis, Akdital stock appears to be undervalued.
The current stock price of MAD1,189.00 is trading 43.4% below its estimated GF Value™ of MAD2,102.26.
GuruFocus considers Akdital to be Possible Value Trap.
Key valuation signals for CAS:AKT:
Days Payable: 95.44 (65% below median its 10-year median of 274.55)
GF Value™: MAD2,102.26 vs. price of MAD1,189.00 (43.4% below fair value)
Industry Position: 64.1% above the Healthcare Providers & Services median (#194 of 607)
No single metric tells the full story. See the CAS:AKT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.
84GF Score
Get the complete analysis for CAS:AKT
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAS:AKT has been successfully added to your 
